Cognate BioServices is a contract development and manufacturing organization specializing in cell and gene-mediated cell therapy. The company has supported the development of FDA-approved therapies and conducted numerous studies in this field.

Cognate BioServices

Biotechnology Research

Charles River Laboratories

Cognate BioServices, a Charles River Company | 12,705 followers on LinkedIn. Your CDMO Partner from Concept to Commercial for Cell &amp; Gene Therapy Products | Cognate BioServices is a leading contract development and manufacturing organization specialized in cell and cell-mediated gene therapies. We pride ourselves in the level of quality and experience we bring to the table. 
Cognate is a dynamic, results-driven, organization focused on providing the broadest range of commercialization services to regenerative medicine, cellular immunotherapy and advance cell therapy companies, organizations and institutions.

Charles Heslen

Quality Assurance Specialist at Cognate BioServices

Nicole Barham

Sr. QC Lab Tech at WMBarr & Companies

Monica Wilson

PD Scientist at CRL

Terri Jerbi

Cognate BioServices, a Charles River Company

DNSSEC

DMARC

Microsoft Azure DNS

Cloudflare DNS

Microsoft

Microsoft Azure

Hubspot Hosted

Accelerated Mobile Pages

Microsoft Azure US East Region

J. Ganjei

Chief Business Officer and Director

Mike Stella

VP, Information Systems

Karim Khoury

Vice President, People & Culture

Roy Cohen

Tim Mitchell

Director, IT Operations

B.j. Zoppa

Sr. Director of Quality

Barry Conner

Controller

Brondelyn Mcgee

Engineering

Chris Schilling

Director Quality Control Analytics

Clifford Froelich

Evis Hursever

Shari Lisa Piré

Chief Legal Officer

Michael Stella

Chief Business Officer

Health Care Acquired Companies (Top 10K)

Manufacturing Acquired Companies With Less Than $1B in Revenue

Maryland Companies With More Than 10 Employees (Top 10K)

Maryland Acquired Companies

Cognate Bioservices is a fully-integrated contract bioservices organization providing the highest level of scientific and management expertise. Cognate provides full development and cGMP manufacturing services to companies and institutions engaged in the development of cell-based products. The combination of highly experienced staff, successful track records and cGMP facilities makes Cognate one of the most qualified contract manufacturers of cell-based products in the world today.

Essex Woodlands Healthcare Partners

Series B - Cognate BioServices

Venture Round - Cognate BioServices

Tennenbaum Capital Partners

Treatment and Processing of Materials Services

Hanover

Maryland

United States

North America

Biological Safety Testing Products and Services Market to Surge to USD 10.51 Billion by 2032, Growing at a 10.10% CAGR

Viral Vectors and Plasmid DNA Manufacturing Market Size to Hit Eyes USD 4.98 Billion by 2027 | CAGR of 24.9%

Life Sciences BPO Market Size To Hold USD 978.48 Billion By ...

Pharmaceutical Aseptic Fill & Finish CMO Market to Witness ...

Charles River Acquires Cell and Gene Therapy CDMO Cognate for $875M

EW Healthcare invests in Cognate BioServices

Comprehensive development and manufacturing services for cell and gene-mediated cell therapies.

HTML5

Google Fonts

Google Compute Engine

Google Tag Manager

Starfield SSL

Google Analytics

Apache Server

HubSpot Forms

Comodo PositiveSSL Certificates

Lead Flows

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 10, 2024 8:58 AM	80cb141f
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 10, 2024 8:58 AM	2db584eb
crunchbase trigger	general	Nov 27, 2024 12:50 PM	ac1bdcaa
crunchbase profile	general	Nov 28, 2024 11:08 AM	0261bc89
li profile	general	Nov 10, 2024 8:58 AM	c77bb1c4
translate crunchbase fundingrounds	general	Nov 28, 2024 9:18 PM	ea52c71e
peers	general	Nov 10, 2024 8:58 AM	c2b9258b
news basic	general	Nov 10, 2024 8:58 AM	71fac5ed
bundesanzeiger	filings
financials download nd	financials
private financials	financials

COGN

COM:COGNATEBIOSERVICES

Cognate BioServices